Gabelli Funds’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16M | Sell |
263,780
-30,370
| -10% | -$1.77M | 0.11% | 236 |
|
|
2025
Q4 | $15.9M | Sell |
294,150
-7,200
| -2% | -$346K | 0.11% | 231 |
|
|
2025
Q3 | $13.6M | Hold |
301,350
| – | – | 0.09% | 263 |
|
|
2025
Q2 | $13.9M | Sell |
301,350
-17,200
| -5% | -$844K | 0.1% | 253 |
|
|
2025
Q1 | $19.4M | Buy |
318,550
+3,200
| +1% | +$187K | 0.15% | 185 |
|
|
2024
Q4 | $17.8M | Sell |
315,350
-19,450
| -6% | -$1.09M | 0.13% | 210 |
|
|
2024
Q3 | $17.3M | Sell |
334,800
-31,650
| -9% | -$1.48M | 0.12% | 224 |
|
|
2024
Q2 | $15.2M | Sell |
366,450
-29,600
| -7% | -$1.32M | 0.12% | 235 |
|
|
2024
Q1 | $21.5M | Sell |
396,050
-67,645
| -15% | -$3.45M | 0.16% | 181 |
|
|
2023
Q4 | $23.8M | Sell |
463,695
-1,215
| -0.3% | -$63.8K | 0.18% | 152 |
|
|
2023
Q3 | $27M | Sell |
464,910
-19,150
| -4% | -$1.17M | 0.22% | 127 |
|
|
2023
Q2 | $31M | Sell |
484,060
-6,540
| -1% | -$439K | 0.23% | 112 |
|
|
2023
Q1 | $34M | Buy |
490,600
+2,875
| +0.6% | +$203K | 0.26% | 105 |
|
|
2022
Q4 | $35.1M | Sell |
487,725
-2,950
| -0.6% | -$222K | 0.27% | 93 |
|
|
2022
Q3 | $34.9M | Sell |
490,675
-20,223
| -4% | -$1.47M | 0.29% | 88 |
|
|
2022
Q2 | $39.3M | Sell |
510,898
-13,140
| -3% | -$1M | 0.3% | 82 |
|
|
2022
Q1 | $38.3M | Sell |
524,038
-23,550
| -4% | -$1.58M | 0.25% | 103 |
|
|
2021
Q4 | $34.1M | Sell |
547,588
-69,658
| -11% | -$4.09M | 0.22% | 131 |
|
|
2021
Q3 | $36.5M | Sell |
617,246
-29,916
| -5% | -$1.97M | 0.24% | 112 |
|
|
2021
Q2 | $43.2M | Sell |
647,162
-3,380
| -0.5% | -$220K | 0.28% | 101 |
|
|
2021
Q1 | $41.1M | Buy |
650,542
+31,242
| +5% | +$1.94M | 0.28% | 101 |
|
|
2020
Q4 | $38.4M | Sell |
619,300
-76,950
| -11% | -$4.73M | 0.27% | 103 |
|
|
2020
Q3 | $42M | Sell |
696,250
-41,000
| -6% | -$2.47M | 0.33% | 79 |
|
|
2020
Q2 | $43.4M | Sell |
737,250
-425,310
| -37% | -$25.4M | 0.35% | 79 |
|
|
2020
Q1 | $64.8M | Sell |
1,162,560
-56,840
| -5% | -$3.47M | 0.58% | 33 |
|
|
2019
Q4 | $78.3M | Buy |
1,219,400
+569,400
| +88% | +$32.6M | 0.51% | 39 |
|
|
2019
Q3 | $33M | Sell |
650,000
-26,987
| -4% | -$1.27M | 0.22% | 135 |
|
|
2019
Q2 | $30.7M | Sell |
676,987
-12,500
| -2% | -$582K | 0.2% | 148 |
|
|
2019
Q1 | $32.9M | Sell |
689,487
-32,300
| -4% | -$1.61M | 0.21% | 142 |
|
|
2018
Q4 | $37.5M | Sell |
721,787
-3,000
| -0.4% | -$161K | 0.26% | 107 |
|
|
2018
Q3 | $45M | Buy |
724,787
+700
| +0.1% | +$41.5K | 0.26% | 113 |
|
|
2018
Q2 | $40.1M | Sell |
724,087
-25,000
| -3% | -$1.35M | 0.24% | 121 |
|
|
2018
Q1 | $47.4M | Buy |
749,087
+27,700
| +4% | +$1.78M | 0.28% | 94 |
|
|
2017
Q4 | $44.2M | Sell |
721,387
-106,000
| -13% | -$6.63M | 0.25% | 109 |
|
|
2017
Q3 | $52.7M | Sell |
827,387
-23,500
| -3% | -$1.37M | 0.3% | 93 |
|
|
2017
Q2 | $47.4M | Buy |
850,887
+11,000
| +1% | +$599K | 0.28% | 105 |
|
|
2017
Q1 | $45.7M | Buy |
839,887
+39,100
| +5% | +$2.14M | 0.27% | 106 |
|
|
2016
Q4 | $46.8M | Sell |
800,787
-179,176
| -18% | -$9.8M | 0.28% | 98 |
|
|
2016
Q3 | $52.8M | Sell |
979,963
-94,100
| -9% | -$6.04M | 0.31% | 89 |
|
|
2016
Q2 | $79M | Sell |
1,074,063
-74,000
| -6% | -$5.23M | 0.47% | 45 |
|
|
2016
Q1 | $73.3M | Buy |
1,148,063
+49,400
| +4% | +$3.12M | 0.44% | 52 |
|
|
2015
Q4 | $75.6M | Sell |
1,098,663
-2,000
| -0.2% | -$132K | 0.46% | 49 |
|
|
2015
Q3 | $65.2M | Buy |
1,100,663
+16,000
| +1% | +$1.02M | 0.39% | 67 |
|
|
2015
Q2 | $72.2M | Sell |
1,084,663
-1,800
| -0.2% | -$119K | 0.38% | 65 |
|
|
2015
Q1 | $70.1M | Buy |
1,086,463
+9,000
| +0.8% | +$563K | 0.36% | 74 |
|
|
2014
Q4 | $63.6M | Buy |
1,077,463
+25,500
| +2% | +$1.44M | 0.31% | 95 |
|
|
2014
Q3 | $53.8M | Buy |
1,051,963
+24,200
| +2% | +$1.21M | 0.27% | 110 |
|
|
2014
Q2 | $49.9M | Sell |
1,027,763
-44,824
| -4% | -$2.21M | 0.25% | 123 |
|
|
2014
Q1 | $55.7M | Sell |
1,072,587
-107,400
| -9% | -$5.71M | 0.29% | 99 |
|
|
2013
Q4 | $62.7M | Sell |
1,179,987
-80,700
| -6% | -$4.11M | 0.33% | 82 |
|
|
2013
Q3 | $58.3M | Sell |
1,260,687
-7,800
| -0.6% | -$342K | 0.33% | 86 |
|
|
2013
Q2 | $56.7M | Buy |
+1,268,487
| New | +$55.1M | 0.34% | 80 |
|
Other funds holding BMY
VCM
VPM
Gabelli Funds's BMY Position: Q1 2026 in Review
Gabelli Funds reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q1 2026, selling an estimated $1.77M and leaving 263,780 shares worth $16M. The position accounts for 0.11% of the portfolio, ranked #236.
Gabelli Funds first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $79M in Q2 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Gabelli Funds held 263,780 shares of Bristol-Myers Squibb worth $16M as of Q1 2026.
- Gabelli Funds sold 30,370 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.77M.
- Bristol-Myers Squibb made up 0.11% of Gabelli Funds's portfolio in Q1 2026, its #236 holding.
- Gabelli Funds first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Gabelli Funds's Bristol-Myers Squibb position peaked at $79M in Q2 2016.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.